Intuitivesurgicalinc — Trading Ideas on TradingView

Intuit Inc. (NASDAQ: INTU) Surges 8% on Strong Earnings Beat Intuit Inc. (NASDAQ: INTU), a leading provider of financial management, compliance, and marketing solutions, saw its stock surge 8% in premarket trading following an impressive earnings beat. The company’s strong financial performance, coupled with increasing demand for its AI-driven financial services software, has positioned NASDAQ:INTU for a potential breakout. AI Expansion and Tax Season Demand Intuit, the maker of TurboTax, QuickBooks, and Credit Karma, has been capitalizing on the growing demand for AI-powered financial solutions. The ongoing tax season in the U.S. has further boosted demand for its software, with the bulk of tax filings expected in Q3. In its latest earnings report, Intuit exceeded Wall Street expectations, reporting second-quarter revenue of $3.96 billion, surpassing the estimated $3.83 billion. Adjusted earnings per share (EPS) came in at $3.32, significantly outperforming estimates of $2.58. However, while Intuit’s Q3 revenue forecast of $7.55 billion–$7.60 billion surpassed the analyst consensus of $7.51 billion, its adjusted profit per share projection of $10.89–$10.95 fell short of the expected $11.48. Despite workforce reductions in 2024, Intuit rapidly filled vacant positions, underscoring its operational efficiency and ability to scale talent acquisition. The company's AI-powered assistant, Intuit Assist, launched in November 2024 for QuickBooks, is further streamlining tax and financial management tasks, enhancing productivity for small businesses and individuals alike. Technical Outlook As of the time of writing, NASDAQ:INTU has surged 8% in premarket trading, forming a bullish engulfing pattern. The stock had previously closed down 2.2% in the last session, trading below key moving averages (MA). However, this premarket jump places NASDAQ:INTU on the cusp of a breakout. Key technical indicators suggest room for further upside: - Relative Strength Index (RSI): Currently at 54, indicating ample room for continued bullish momentum before entering overbought territory. - Fibonacci Retracement Support: The 38.2% Fibonacci retracement level is acting as a key support zone, potentially providing a cushion against pullbacks. - Breakout Potential: A decisive move above the 1-month high could push the stock toward the 38.2% Fibonacci extension zone, paving the way for new resistance levels and a sustained bullish run.

ISRG Down 2% in Premarket Trading Despite Beating Expectations Intuitive Surgical, Inc. (ISRG) experienced a 2% dip in premarket trading on Friday despite reporting robust fourth-quarter earnings that exceeded analysts’ expectations. The medical device company, known for its revolutionary da Vinci surgical robots, continues to showcase its dominance in the minimally invasive surgery market. Here’s a detailed look at the company’s performance, supported by fundamental and technical insights. Strong Financial Performance Intuitive Surgical reported a 25% year-over-year increase in fourth-quarter revenue, reaching $2.41 billion. This figure surpassed the consensus estimate compiled by Visible Alpha, reinforcing the company’s strong growth trajectory. Earnings rose to $686 million, or $1.88 per share, up from $606 million, or $1.69 per share, a year ago. These figures also beat analysts’ expectations, demonstrating the company’s profitability. Operational Highlights Procedure Growth: The number of procedures performed using da Vinci surgical devices increased by 18% year-over-year, signaling strong demand for Intuitive Surgical’s minimally invasive technology. System Installations: The company installed 493 da Vinci systems during the quarter, compared to 415 systems a year earlier. This growth highlights the increasing adoption of its surgical solutions. Future Outlook Intuitive Surgical expects da Vinci procedures to grow by 13% to 16% in 2025. However, the company anticipates a 1 to 2 percentage point decline in its adjusted gross profit margin due to potential new tariffs, which could materially impact its financials. Technical Analysis Despite the strong earnings report, NASDAQ:ISRG shares fell by 2% in premarket trading. The stock’s overbought condition, indicated by an RSI of 75 as of Thursday’s close, suggests a potential for short-term correction. - Gap Down Pattern: Historically, gap-down patterns in NASDAQ:ISRG stock have been filled, hinting at a possible rebound in the coming sessions. This historical behavior aligns with the broader market’s tendency to correct temporary gaps. Key Support and Resistance Levels - Support: Immediate support lies at the 38.2% Fibonacci retracement level, which could act as a cushion in case of further price correction. - Resistance: The pivot point is situated above the 1-month high, presenting a significant barrier for upward momentum. Moving Averages The stock is trading above its 50-day, 100-day, and 200-day moving averages, underscoring its bullish trend in the medium to long term. This alignment of key moving averages strengthens the case for continued upside potential. Market Context - All-Time High: NASDAQ:ISRG shares closed at an all-time high on Thursday, marking a 62% gain over the past year. This performance underscores investor confidence in the company’s long-term prospects. - Sector Strength: The growing adoption of robotic surgical systems positions Intuitive Surgical as a leader in the medical device industry, benefiting from the broader trend toward minimally invasive procedures. Conclusion Intuitive Surgical’s robust financial results and operational milestones underscore its leadership in the surgical robotics market. While the current dip in premarket trading reflects short-term market dynamics, the stock’s strong technical indicators and historical performance suggest a potential rebound. Investors should monitor key support and resistance levels, along with updates on tariff developments, to assess the stock’s trajectory. With a bullish continuation pattern likely in play, NASDAQ:ISRG remains a compelling option for long-term growth-oriented investors.

Intuitive Surgical is Set to Release its Quarterly 2024 Results Intuitive Surgical is set to release its Quarterly 2024 results, highlighting its significant impact on the healthcare industry. The company's innovative robotic systems have transformed surgery, leading to a remarkable 22,000% increase in stock price over its lifetime. Now an industry giant with a market capitalization of $161 billion, questions about Intuitive Surgical's long-term growth and stock investment potential abound. Intuitive Surgical, founded in the mid-1990s, provides robotic systems that enhance minimally invasive surgeries, helping surgeons reduce errors, improve mobility, and achieve better patient outcomes with smaller incisions. Over 60,000 surgeons have trained on its da Vinci system, and as of Q2 2024, the company has over 9,800 installed systems, with a 14% year-over-year growth in installations. Investors value two main aspects of Intuitive Surgical's business: the reliance on system maintenance, which has increased recurring revenue from 71% in 2016 to 83% last year, making cash flow more predictable, and substantial growth potential outside the U.S., with only 3,818 of an estimated 165,000 global hospital sites currently using their systems. However, the stock's substantial rise poses concerns about whether this growth is already accounted for in its valuation. Over the past decade, Intuitive Surgical shares ( NASDAQ:ISRG ) have appreciated nearly 800%, resulting in heightened market expectations that may lead to a difficult reset if future results fall short. Analysts anticipate average earnings growth of 17% annually over the next three to five years, which may not be sufficient to justify the stock’s forward price-to-earnings (P/E) ratio of 69. With a PEG ratio nearly at 4, this suggests that the stock is overvalued relative to its expected growth. Despite its recent upward trend since November 2023, indicated by a balanced Relative Strength Index (RSI) of 53, the stock is presently deemed too expensive for investors seeking strong returns. Therefore, while Intuitive Surgical ( NASDAQ:ISRG ) shows promising long-term growth potential, it may be wise to consider it as a target for investment when shares drop below current levels.

Intuitive Surgical ($ISRG) Set to Release its Financial Results This week, Intuitive Surgical (NASDAQ: NASDAQ:ISRG ) is set to release its financial results, and its stock price is expected to be in the spotlight. The robotics industry giant's product, da Vinci, is utilized by numerous doctors for performing minimally invasive surgeries. Intuitive Surgical's performance has been noteworthy in recent years, with a surge in demand for its product. Consequently, its total revenue increased from $4.47 billion in 2019 to over $7.1 billion in 2023. In the fourth quarter of the previous year, the company reported a 17% increase in revenue to $1.66 billion, with a 22% rise in its instruments and accessories business generating $1.14 billion in revenue. Additionally, the company's revenue from its systems rose to $480 million, with 415 da Vinci surgical systems sold in comparison to 369 in the same period in 2023. This week's earnings report is expected to have a significant impact on the ISRG stock price. Analysts predict that the company's revenue for Q1 will improve from $1.65 billion last year to $1.81 billion. The company's growth is expected to continue, with investors anticipating revenue of $1.98 billion in Q2. The average estimate for the year is that its revenue will reach $8 billion, followed by $9.24 billion in 2026. Intuitive Surgical's ( NASDAQ:ISRG ) strong device sales and recurring revenue, combined with its robust balance sheet, have led analysts to be bullish on the company's prospects. The company has a cash and equivalents balance of more than $7.34 billion and minimal debt. In the last quarter, it generated over $92.6 million in interest income. Recently, Stifel, Citigroup, Mizuho, and Barclays have upgraded the stock, with an average target of $414.80, higher than the current $378.55. The NASDAQ:ISRG shares peaked at $403.97 in March, a 123% increase from its lowest point in 2022. However, the stock has pulled back as some investors took profits while awaiting the financial results. Intuitive Surgical's stock has retested the crucial support level at $370, which was its highest swing in December last year. Typically, a break and retest pattern is a bullish sign in the market. The only potential risk is that it has formed a double-top pattern near $403. The key support and resistance levels to watch are $360 (July 23rd high) and $403, respectively. In conclusion, Intuitive Surgical's financial results this week are anticipated to be a significant factor in determining the company's future stock performance. The company's strong balance sheet, recurring revenue, and robust device sales are among the factors that have led industry analysts to be optimistic about the company's prospects.

ISRG - Intuitive Surgical Inc - Buy Zone According to the market behaviour, ISRG has been rising sharply on the one hour, five hours, daily, and weekly charts. Technical analysis indicates that the next target will $327, and if it crosses that level and closes above successfully, the next target for the market will be $340 & 354. Italian Translation: Secondo il comportamento del mercato, l'ISRG è in forte aumento sui grafici di un'ora, cinque ore, giornalieri e settimanali. L'analisi tecnica indica che il prossimo obiettivo sarà 327 dollari e, se supera quel livello e chiude con successo al di sopra, il prossimo obiettivo per il mercato sarà 340 e 354 dollari. German Translation: Dem Marktverhalten zufolge ist ISRG auf den Ein-Stunden-, Fünf-Stunden-, Tages- und Wochen-Charts stark gestiegen. Die technische Analyse zeigt, dass das nächste Ziel bei 327 US-Dollar liegt. Wenn es dieses Niveau überschreitet und erfolgreich darüber schließt, wird das nächste Ziel für den Markt bei 340 und 354 US-Dollar liegen.